D+005
Today
2025.05.20
2025.05.20
Program
Scientific Program
- May 15(Thu)
- 09:00-10:30
- KOR_Year in Review, Clinical
- Room 1 (3F)
- Korean (AI Translation)
- Chairs
- Shin-Seok Lee (Chonnam Nat'l Univ., Korea)
- Myeungsu Lee (Wonkwang Univ., Korea)
- 09:00-09:30
- Crystal arthropathy
- Yun Hong Cheon (Gyeongsang Nat'l Univ., Korea)
- 09:30-10:00
- Large vessel vasculitis
- Oh Chan Kwon (Yonsei Univ., Korea)
- 10:00-10:30
- IgG4-related disease
- Hyoun-ah Kim (Ajou Univ., Korea)
- May 15(Thu)
- 11:00-12:00
- Presidential Plenary Session
- Room 1 (3F)
- Korean (AI Translation)
- Chair
- Hoon-Suk Cha (Sungkyunkwan Univ., Korea)
- 11:00-11:30
- Innovating rheumatology: Bridging tradition and tomorrow
- Tae-Hwan Kim (Hanyang Univ., Korea)
- 11:30-12:00
- Navigating new frontiers in Korean rheumatology: A visionary's perspective
- Jung Soo Song (Chung-Ang Univ., Korea)
- May 15(Thu)
- 12:00-13:00
- Luncheon Symposium 1 [Johnson&Johnson]
- Advancing RA Care: Practical Insight of Golimumab IV
- Room 1 (3F)
- Korean (AI Translation)
- Chair
- Chang Keun Lee (Univ. of Ulsan, Korea)
- 12:00-13:00
- Optimizing RA care with Golimumab IV: Clinical impact from the first dose
- So-Young Bang (Hanyang Univ., Korea)
- May 15(Thu)
- 13:00-14:30
- International Symposium 1_Insights from the Editorial Board: Navigating the World of Publishing in Leading Medical Journals
- Room 1 (3F)
- ENG/KOR (AI Translation)
- Chairs
- Young Ho Lee (Korea Univ., Korea)
- Hae-Rim Kim (Konkuk Univ., Korea)
- 13:00-13:30
- Strategies for publishing in high impact journals: The Lancet Rheumatology
- Anna Clark (The Lancet Rheumatology, UK)
- 13:30-14:00
- The distinctiveness and mission of IJRD as a leading journal in the rheumatology of the Asian-Pacific region
- James Cheng-Chung Wei (Chung Shan Medical Univ., Taiwan)
- 14:00-14:30
- Future direction of Journal of Rheumatic Diseases
- Min-Chan Park (Yonsei Univ., Korea)
- May 15(Thu)
- 15:30-17:30
- International Joint Symposium (KCR and APLAR member)
- Room 1 (3F)
- English (AI Translation)
- Chairs
- Kichul Shin (Seoul Nat'l Univ., Korea)
- Lai-Shan Tam (The Chinese Univ. of Hong Kong, Hong Kong)
- 15:30-16:00
- Sjögren’s Syndrome: New world revealed by multi-omics analysis
- Tsutomu Takeuchi (Saitama Medical Univ., Japan)
- 16:00-16:30
- Optimal application MRI in axial spondyloarthritis harnessing AI
- Ashish Mathew (Christian Medical College Vellore, India)
- 16:30-17:00
- What’s new in Gout management?
- Nicola Dalbeth (Univ. of Auckland/Health New Zealand, New Zealand)
- 17:00-17:30
- Unseen burden: SLE in women of childbearing age
- Jisoo Lee (Ewha Womans Univ., Korea)
- May 15(Thu)
- 17:30-18:30
- Evening Symposium 1 [Eisai Korea Inc.]
- A Well-balanced JAKi for Patients with RA
- Room 1 (3F)
- Korean (AI Translation)
- Chair
- Bin Yoo (Univ. of Ulsan, Korea)
- 17:30-18:30
- Efficacy and safety of Jyseleca for the treatment of rheumatoid arthritis: Recent updates
- Doo-Ho Lim (Univ. of Ulsan, Korea)
- May 15(Thu)
- 08:00-09:00
- Breakfast Symposium 1 [Samsung Bioepis]
- Behçet Disease
- Room 2 (3F)
- Korean (AI Translation)
- Chair
- Sang-il Lee (Gyeongsang Nat'l Univ., Korea)
- 08:00-09:00
- Treatment options for Behçet's Disease: The emerging role of biologic therapies
- You-Jung Ha (Seoul Nat'l Univ., Korea)
- May 15(Thu)
- 12:00-13:00
- Luncheon Symposium 2 [Abbvie]
- Unlocking the Therapeutic Potential of JAK Inhibitors in Axial Spondyloarthritis Management
- Room 2 (3F)
- Korean (AI Translation)
- Chair
- Geun Tae Kim (Kosin Univ., Korea)
- 12:00-13:00
- Comprehensive management of axial spondyloarthritis with Upadacitinib
- Yun Hong Cheon (Gyeongsang Nat'l Univ., Korea)
- May 15(Thu)
- 13:00-14:30
- Free Paper Session 1_Systemic Lupus Erythematosus and Antiphospholipid Syndrome (I)
- Room 2 (3F)
- English (AI Translation)
- Chairs
- Jisoo Lee (Ewha Womans Univ., Korea)
- Chang-Hee Suh (Ajou Univ., Korea)
- 13:00-13:10
- (KO-001) Hypoalbuminemia as a risk factor for recurrent ascites in systemic lupus erythematosus
- Young Eun Kim (Univ. of Ulsan, Korea)
- 13:10-13:20
- (KO-002) Prognostic factors of pulmonary arterial hypertension in Korean patients with systemic lupus erythematosus diagnosed by right heart catheterization
- Ji-Hyoun Kang (Chonnam Nat'l Univ., Korea)
- 13:20-13:30
- (KO-003) Evaluating urinary acetylated proteins as biomarkers for lupus nephritis: A prospective cohort study
- Yeo-Jin Lee (Univ. of Ulsan, Korea)
- 13:30-13:40
- (KO-004) Effect of ultraviolet light exposure on disease activity in patients with systemic lupus erythematosus
- Sung Cheol Jung (Seoul Nat'l Univ., Korea)
- 13:40-13:50
- (KO-005) Early-onset of systemic lupus erythematosus associated with disease activity, clinical features in Malay patients: Preliminary findings from iLUPUS study
- Muhammad Fazrul Azim Abd halil (Ministry of Health Malaysia, Malaysia)
- 13:50-14:00
- (KO-006) Distinct gut microbiome and metabolome profiles in Korean systemic lupus erythematosus patients
- Youngjae Park (The Catholic Univ. of Korea, Korea)
- 14:00-14:10
- (KO-007) Gut microbiota-derived metabolite trimethylamine N-oxide in Korean patients with systemic lupus erythematosus
- Jiwon Yang (The Catholic Univ. of Korea, Korea)
- 14:10-14:20
- (KO-008) Validation of the newly developed definition of lupus low disease activity and its prognostic significance in patients with systemic lupus erythematosus
- Ji-Hyoun Kang (Chonnam Nat'l Univ., Korea)
- 14:20-14:30
- (KO-009) Longitudinal fluctuations of antiphospholipid antibodies and vascular events in a cohort of newly diagnosed systemic lupus erythematosus: A two year follow up study
- Ritesh Kumar Mishra (Jawaharlal Institute of Postgraduate Medical Education and Research, India)
- May 15(Thu)
- 15:30-16:30
- Free Paper Session 2_Systemic Lupus Erythematosus and Antiphospholipid Syndrome (II)
- Room 2 (3F)
- English (AI Translation)
- Chair
- Hye-Soon Lee (Hanyang Univ., Korea)
- 15:30-15:40
- (KO-010) TRIM6 increases the risk of systemic lupus erythematosus by reducing interleukin-10 levels: A multiomics mediation mendelian randomization analysis
- Lei Chen (Sichuan Univ., China)
- 15:40-15:50
- (KO-011) Identification of plasma causal proteins related to macrophage activation in systemic lupus erythematosus via multi-omics analysis
- Manrong He (Sichuan Univ., China)
- 15:50-16:00
- (KO-012) Suppression of CXCL10 via progesterone-induced blocking factor 1 in the systemic lupus erythematosus
- Young Eun Kim (Univ. of Ulsan, Korea)
- 16:00-16:10
- (KO-013) Novel STAT3 inhibitor exhibits therapeutic potential in murine lupus
- Wook-Young Baek (Ajou Univ., Korea)
- 16:10-16:20
- (KO-014) CD10high low-density granulocytes is a potential marker of disease activity in antiphospholipid syndrome
- Xiaocong Huo (Peking Univ., China)
- 16:20-16:30
- (KO-015) Allopurinol attenuates lupus disease activity by lowering uric acid levels in MRL/lpr mice
- Yeo-Jin Lee (Univ. of Ulsan, Korea)
- May 15(Thu)
- 16:30-17:30
- Free Paper Session 4_Sjögren's Syndrome
- Room 2 (3F)
- English (AI Translation)
- Chair
- Seung-Ki Kwok (The Catholic Univ. of Korea, Korea)
- 16:30-16:40
- (KO-022) Effectiveness of glucocorticoid in Sjögren’s syndrome: A real-world cohort study
- Xiangpeng Wang (Peking Union Medical College Hosp., China)
- 16:40-16:50
- (KO-023) Minimally invasive, rapid, and safe method for minor salivary gland biopsy using a chalazion clamp and a needle
- Ki-Jeong Park (Chonnam Nat'l Univ., Korea)
- 16:50-17:00
- (KO-024) Antagonist of sphingosine 1-phosphate ameliorates Sjögren's syndrome by reciprocal regulation of germinal center B cells and Breg cells
- JeongWon Choi (The Catholic Univ. of Korea, Korea)
- 17:00-17:10
- (KO-025) Clinical implications of expression of costimulatory molecules in Sjögren's syndrome
- Youngjae Park (The Catholic Univ. of Korea, Korea)
- May 15(Thu)
- 17:30-18:30
- Evening Symposium 2 [Astellas]
- Innovations in Lupus Nephritis Management
- Room 2 (3F)
- English (AI Translation)
- Chair
- Jung-Yoon Choe (Daegu Catholic Univ., Korea)
- 17:30-18:30
- Role of calcineurin inhibitors in the current therapeutic landscape for lupus nephritis
- Tak Mao Chan (The Univ. of Hong Kong, Hong Kong)
- May 15(Thu)
- 09:00-10:30
- KOR_Year in Review, Basic
- Room 3 (5F)
- Korean (AI Translation)
- Chairs
- Wan-Uk Kim (The Catholic Univ. of Korea, Korea)
- Eon Jeong Nam (Kyungpook Nat'l Univ., Korea)
- 09:00-09:30
- Recent advances in basic research on SLE
- Seokchan Hong (Univ. of Ulsan, Korea)
- 09:30-10:00
- Recent advances in basic research on RA
- Seungwoo Han (Kyungpook Nat'l Univ., Korea)
- 10:00-10:30
- Advances in Systemic Sclerosis: Emerging pathogenic insights and breakthroughs in basic research
- Su-Jin Moon (The Catholic Univ. of Korea, Korea)
- May 15(Thu)
- 12:00-13:00
- Luncheon Symposium 3 [Pfizer & Hanlim MS]
- Beyond 10 Years Experienced JAK-i in RA, Tofacitinib
- Room 3 (5F)
- Korean (AI Translation)
- Chair
- Yun Jong Lee (Seoul Nat'l Univ., Korea)
- 12:00-13:00
- Long term strategy for the treatment of patients with RA
- Seokchan Hong (Univ. of Ulsan, Korea)
- May 15(Thu)
- 13:00-14:30
- KCR-KASID Joint Symposium
- Room 3 (5F)
- English (AI Translation)
- Chairs
- Seong Ryul Kwon (Inha Univ., Korea)
- Sung-Ae Jung (Ewha Womans Univ., Korea)
- 13:00-13:30
- Connections between spondyloarthritis and IBD: The immunobiology link
- Tae-Jong Kim (Chonnam Nat'l Univ., Korea)
- 13:30-14:00
- GI involvement of Behcet's disease: Another subset of IBD
- Jae Hee Cheon (Yonsei Univ., Korea)
- 14:00-14:30
- New aspects of IBD treatment: From cytokines to small molecules
- Sung Noh Hong (Sungkyunkwan Univ., Korea)
- May 15(Thu)
- 15:30-16:30
- Free Paper Session 3_Muscle Disease Including Myopathies
- Room 3 (5F)
- English (AI Translation)
- Chair
- Jinhyun Kim (Chungnam Nat'l Univ., Korea)
- 15:30-15:40
- (KO-016) Anti-mitochondrial M2 antibody is associated with cardiac involvements and immune-mediate necrotizing myopathy in idiopathic inflammatory myopathies: A long-term retrospective cohort study
- Yiyun Pang (Peking Union Medical College, China)
- 15:40-15:50
- (KO-017) Disease trajectory in anti-MDA5 dermatomyositis patients presented with different stages of interstitial lung disease
- Ting-Yuan Lan (Nat'l Taiwan Univ., Taiwan)
- 15:50-16:00
- (KO-018) Cardio-Pulmonary Exercise Rest (CPET) performance and the factors associated with it in patients with Idiopathic Inflammatory Myopathies (IIM)
- Lovely Kumari (Jawaharlal Institute of Postgraduate Medical Education and Research (JIPMER), India)
- 16:00-16:10
- (KO-019) Transcriptomic analysis of muscle tissue shows increased myogenesis and a distinct macrophage population in idiopathic inflammatory myopathy
- Seon Uk Kim (Seoul Nat'l Univ., Korea)
- 16:10-16:20
- (KO-020) Type 1 interferon signature and B lymphocyte subsets in juvenile dermatomyositis: Correlations with clinical parameters and disease activity
- Aditya Dod (Post Graduate Institute of Medical Education and Research, India)
- 16:20-16:30
- (KO-021) Mitochondrial transplantation as a novel therapeutic approach in idiopathic inflammatory myopathy
- Eun Young Lee (Seoul Nat'l Univ., Korea)
- May 15(Thu)
- 16:30-17:30
- Free Paper Session 5_Vasculitis, Systemic Sclerosis and Fibromyalgia
- Room 3 (5F)
- English (AI Translation)
- Chair
- Sang-Won Lee (Yonsei Univ., Korea)
- 16:30-16:40
- (KO-026) Outcomes of Kawasaki disease in children with spontaneous defervescence- our experience at Chandigarh, North India
- Yamini Sharma (Post Graduate Institute of Medical Education and Research (PGIMER), India)
- 16:40-16:50
- (KO-027) Kawasaki disease, immunodeficiency and pediatric unrelated conditions: The pediatrician’s conundrum
- Radhika Semwal (Post Graduate Institute of Medical Education and Research (PGIMER), India)
- 16:50-17:00
- (KO-028) Ferroptosis inhibition alleviates fibrosis in murine models of systemic sclerosis
- Su-Jin Moon (The Catholic Univ. of Korea, Korea)
- 17:00-17:10
- (KO-029) Association of serum homocysteine, folic acid, and vitamin B12 levels in juvenile fibromyalgia patients
- Pardeep Kumar (F H Medical College & Hosp., India)
- May 15(Thu)
- 17:30-18:30
- Evening Symposium 3 [Lilly]
- Optimizing Axial Spondyloarthritis Management
- Room 3 (5F)
- English (AI Translation)
- Chair
- Tae-Hwan Kim (Hanyang Univ., Korea)
- 17:30-18:30
- Treating patients with different CRP level
- Raj Sengupta (The Royal Nat'l Hosp. for Rheumatic Diseases, Bath, UK)
- May 15(Thu)
- 14:30-15:30
- Poster Viewing & Poster Tour 1
- Poster Zone (5F)
- ENG/KOR
- Tour_KP-001
- Multisystem inflammatory syndrome in children (MIS-C) with hyperferritinemia: A Korean study
- Soo-Young Lee (College of Medicine, The Catholic Univ. of Korea, Korea)
- Tour_KP-002
- Characterizing infusion-related reactions in patients with rheumatoid arthritis treated with biologic synthetic DMARDs: Observations from the KOBIO registry
- Ji-Won Kim (Ajou Univ., Korea)
- Tour_KP-003
- The association of renal expression of long non-coding RNA lnc-DC with clinical parameters in lupus nephritis
- So Hye Nam (Keimyung University School of Medicine, Korea)
- Tour_KP-004
- Risk of cervical intraepithelial neoplasia during Janus inhibitor treatment in patients with rheumatoid arthritis: A retrospective cohort study
- MIRA Cho (Rheumatology, Asan medical center, Korea)
- Tour_KP-005
- Severe lower limb edema complicating COVID-19 in a rheumatoid arthritis patient: A case report
- Seonghui Kang (Konyang University hospital, Korea)
- KP-006
- The role of DICAM in modulating macrophage differentiation and inflammatory responses via αvβ3 integrin signaling in rheumatoid arthritis
- Youn-Kwan Jung (Gyeongsang National University, Korea)
- KP-007
- Comparison of the incidence of interstitial lung disease in patients with seropositive rheumatoid arthritis using biologic DMARDs, JAK inhibitors, or methotrexate
- Jiyeol Yoon (Severance Hospital, Korea)
- KP-008
- Associations of 6-minute walk distance in patients with rheumatoid arthritis-associated interstitial lung disease
- Sung Hae Chang (Soonchunhyang Univ., Korea)
- KP-009
- A novel scoring system to predict a cancer development in patients with idiopathic inflammatory myopathy
- Yun Kyu Kim (Seoul Nat'l Univ. Hosp., Korea)
- KP-010
- Osteoarthritis contributes to gout exacerbation by inflammatory imprinting of synovial fibroblasts through METTL3/YTHDF2-mediated m6A demethylation of FSP1/S100A4
- Ziyi Chen (Huashan Hosp., China)
- KP-011
- Immune-neuro-endocrine system and gout: Cross-sectional and analytical study
- Maria del Refugio Denise Clavijo cornejo (Instituto Nacional de Rehabilitación, Mexico)
- KP-012
- Distinct characteristics of patients with gout with an underweight or normal body mass index: A single-center retrospective study
- Sung Soo Ahn (Yonsei Univ., Korea)
- KP-013
- Ultrasonographic findings of tophaceous gout initially presenting with bilateral carpal tunnel syndrome
- Seong Hyeok Bak (Soon chun hyang university hospital seoul, Korea)
- KP-014
- Differences in clinical characteristics between elderly-onset gout and younger-onset gout patients
- Hyunsue Do (Kangwon National University School of Medicine, Chuncheon, Korea Department of Internal Medicine, Korea)
- KP-015
- The role of dual-energy CT in predicting gout flares
- MI HYEON Kim (Hallym University Dongtan Sacred Heart Hospital, Korea)
- KP-016
- Association of oral opioid usage and mortality in patients with inflammatory arthritides: A Korean nationwide cohort study
- Sung Soo Ahn (Yonsei Univ., Korea)
- KP-017
- Evaluating the usability of an AI-based chat application for shared decision-making in rheumatoid arthritis patients
- Se Rim Choi (Hanyang Univ., Korea)
- KP-018
- Self-confidence in rheumatology for the primary care physician
- Tsolmon Darisuren (MNUMS, Mongolia)
- KP-019
- Patient preferences for closed non-contact thermotherapy in rheumatic joint cold pain: A discrete choice experiment
- Ping Wan (The Southwest Hospital of AMU, China)
- KP-020
- Myelodysplasia syndrome with trisomy 8 and Behçet-like syndrome
- Shio-Yi Liao (Taipei Veterans General Hospital, Taiwan)
- KP-021
- Amyloidosis -sticky cell syndrome
- Manikandan Gopal (Christian Medical College, Vellore, Tamilnadu, India)
- KP-022
- Germanium telluride nanosheets suppress epidermal proliferation and inflammatory response in human HaCaT keratinocytes and alleviate imiquimod-induced psoriasis mice
- Jieun Han (Yonsei University, Korea)
- KP-023
- Fatal rheumatoid vasculitis associated with antiphospholipid antibody positivity leading to critical limb ischemia
- Jinsu Park (Nat'l Health Insurance Service Ilsan Hosp., Korea)
- KP-024
- Idiopathic inflammatory myopathies (IIM) in southeast Asians – a single centre experience in Malaysia
- KIAH LOON Ng (Malaysian Society of Rheumatology, Malaysia)
- KP-025
- DMARD monitoring with comorbidity considerations in rheumatoid arthritis: A scoping review of guidelines
- Mihye Kwon (Konyang Univ. Hosp., Korea)
- KP-026
- Comparative analysis of rheumatoid arthritis rates in low and high SDI countries (predicted in 2030)
- Najwa Aisya Putri (International Open University, Indonesia)
- KP-027
- Clinical correlations between serum matrix metalloproteinase-3 (MMP-3) levels and disease activity in a mmulti-ethnic Asian population with rheumatoid arthritis
- Lay-Kim Tan (Ministry of Health, Malaysia)
- KP-028
- Risk of non-bacterial opportunistic infections associated with JAK inhibitors versus TNF inhibitors among rheumatoid arthritis patients: A cohort study
- Anna Shin (Seoul National University Bundang Hospital, Korea)
- KP-029
- Patient-level ultrasound joint inflammation variables derived from the EULAR-OMERACT scoring of ultrasound synovitis at the joint-level show good construct validity in patients with rheumatoid arthritis
- York Kiat Tan (Singapore General Hospital, Singapore)
- KP-030
- Age-related disparities in RA treatment: Reduced remission rates in patients aged 70 and above on biologics and JAK inhibitors
- Yoon-Kyoung Sung (Hanyang Univ., Korea)
- KP-031
- Multi-modal prediction of response to Janus kinase inhibitors in patients with severe rheumatoid arthritis
- Bo Young Kim (Gangneung Asan Hospital, University of Ulsan College of Medicine, Korea)
- KP-032
- Comparison of auto-antibodies targeting anti-citrullinated chemokines in diagnostic and prognostic implications discriminating rheumatoid arthritis and juvenile idiopathic arthritis
- Olexandr Korchynskyi (Institute of Biochemistry, Natl.Acad.Sci. Ukraine, Ukraine)
- KP-033
- Establishment of a humanized animal model with clinical characteristics of patients with Sjögren's syndrome
- Jin-Sil Park (Catholic University of Korea, Korea)
- KP-034
- Adalimumab spacing as a risk factor for uveitis recurrence in patients with ankylosing spondylitis
- Yeo-Jin Lee (Univ. of Ulsan, Korea)
- KP-035
- Case report: Severe dilated cardiomyopathy following adalimumab use in a patient with ankylosing spondylitis
- Eunsong Kang (Korea Univ., Korea)
- KP-036
- Evaluating the influence of the ASAS early axial spondyloarthritis definition on radiographic changes in the presence and absence of TNF blocker therapy
- Bora Nam (Hanyang University Hospital for Rheumatic Diseases, Korea)
- KP-037
- Efficacy and retention rate of subcutaneous infliximab in patients with ankylosing spondylitis: One-year result from a single-centre study
- Se Hee Kim (Kyung Hee Univ., Korea)
- KP-038
- Biomarkers for predicting successful tapering of a TNF inhibitor in patients with radiographic axial spondyloarthritis: A pilot study
- Hong Ki Min (Konkuk Univ., Korea)
- KP-039
- Prevalence, progression, and associated factors of enthesopathy at hip and pelvic regions in patients with axial spondyloarthritis: Computed tomography-based assessment
- Seong Hyeok Bak (Soon chun hyang university hospital seoul, Korea)
- KP-040
- Guselkumab and IL-17 inhibitors show comparable treatment persistence and effectiveness in psoriatic arthritis: 6-month interim results of the PsABIOnd observational cohort study
- Kichul Shin (SMG-SNU Boramae Medical Center, Korea)
- KP-041
- Systemic lupus erythematosus presenting as abdominal sasculitis mimicking clostridium difficile infection: A diagnostic and therapeutic dilemma
- Yu Chen Chu (Taipei medical university hospital, Taiwan)
- KP-042
- “I now send my son to pay at the register because I can’t deal with the stares”. A social media analysis on discrimination experiences among individuals living with lupus
- Patrick Brzoska (Witten/Herdecke University, Faculty of Health, School of Medicine, Germany)
- KP-043
- Advances in genomics for SLE: A bibliometric analysis (2014–2024)
- Nurmala Widya Absari (Islamic University of Indonesia, Indonesia)
- KP-044
- Autoantibodies and their relationship with disease activity and hematological disorders in Malay patients with systemic lupus erythematosus: Preliminary findings from iLUPUS study
- En Hong Chua (Faculty of Medicine and Health Sciences, Universiti Putra Malaysia, Serdang, Selangor, Malaysia, Malaysia)
- KP-045
- Identification of differentially expressed genes and key pathways in systemic lupus erythematosus for potential therapeutic targeting
- Nadyatul Husna (dr. Reksodiwiryo Military Hospital Padang, Indonesia)
- KP-046
- Impact of Sjögren's syndrome and its immunological characteristics on reaching remission or low disease activity state in systemic lupus erythematosus patients: A propensity-score matched longitudinal study
- Haoze Zhang (Peking University First Hospital, China)
- KP-047
- Transverse myelitis accompanied by spinal cord infarction in a patient with systemic lupus erythematosus
- Hyunjin Lim (Gyeongsang National University Hospital, Korea)
- KP-048
- A rare intersection: IgG4-related renal disease and systemic lupus erythematosus
- Eun Hye Park (Chung-Ang Univ., Korea)
- KP-049
- Case report: Remission of severe autoimmune hemolytic anemia in a SLE patient after belimumab administration
- Hansun Song (Inha University Hospital, Korea)
- KP-050
- Steroid-resistant lupus nephritis in a young male: A case of successful rituximab therapy and unusual striae complications
- Vivi putri Lesmana (CIpto Mangunkusumo National Hospital, Indonesia)
- KP-051
- Vimentin immunization induces TH2/TH17 cell proliferation and autoantibody production in a novel mouse model of systemic sclerosis
- Seon-Yeong Lee (The Catholic Univ. of Korea, Korea)
- KP-052
- Rheumatoid factor positivity in patients with Eosinophilic Granulomatosis with Polyangiitis (EGPA): An innocent bystander?
- Luca Iorio (University of Padua, Italy)
- KP-053
- Role of CT coronary angiography for coronary artery assessment in Kawasaki disease during the acute phase – Experience from Chandigarh, North India
- Dev Desai (Post Graduate Institute of Medical Education and Research (PGIMER), India)
- KP-054
- Correlation between Intergenerational
- Tan Ting (People's Hospital of Chongqing Banan District, Chongqing, China)
- KP-055
- One case of adult-onset still's disease with fever and epistaxis
- Yangbojun Yang (The Thirteenth People's Hospital of Chongqing, China)
- KP-056
- TIF1γ antibody-positive dermatomyositis with concurrent tumors: Characteristics and literature review
- Tan Ting (People's Hospital of Chongqing Banan District, Chongqing, China)
- KP-057
- Drug prediction and molecular docking of hub genes involved in mitophagy and ferroptosis in osteoarthritis
- Luo Xingye (NSMC, China)
- KP-058
- Effect of video music therapy based on patient feedback on pain relief in osteoarthritis
- Tan Ting (People's Hospital of Chongqing Banan District, Chongqing, China)
- KP-059
- Effect of video music therapy based on patient feedback on pain relief in osteoarthritis
- Tan Ting (People's Hospital of Chongqing Banan District, Chongqing, China)
- KP-059
- Physician global assessments in systemic sclerosis is related to subclinical cardiac involvement
- Huilin He (Peking Union Medical College Hospital, China)
- KP-060
- The co-occurrence of IgG4-related disease and malignancy: Insights from a prospective cohort study
- Yufei Guo (The First Medical Center of PLA General Hospital, Beijing, China)
- KP-061
- The ABCG2 rs2231142 SNP is associated as a risk factor for gout, with increased ABCG2 gene methylation and lower ABCG2 gene expression
- Ambar López Macay (Instituto Nacional de Rehabilitación, Mexico)
- May 16(Fri)
- 08:00-09:00
- Breakfast Symposium 2 [Abbvie]
- Unlocking the Therapeutic Potential of JAK Inhibitors in Rheumatoid Arthritis Management
- Room 1 (3F)
- Korean (AI Translation)
- Chair
- Sang-Heon Lee (Konkuk Univ., Korea)
- 08:00-09:00
- Persistence of remission in rheumatoid arthritis with Upadacitinib
- Yeon-Ah Lee (Kyung Hee Univ., Korea)
- May 16(Fri)
- 09:00-10:00
- Keynote Lecture 1
- Room 1 (3F)
- English (AI Translation)
- Chair
- Seung Cheol Shim (Chungnam Nat'l Univ., Korea)
- 09:00-10:00
- Multi-omics approach in rheumatology: From cells to precision medicine
- Keishi Fujio (The Univ. of Tokyo, Japan)
- May 16(Fri)
- 10:30-12:00
- International Symposium 2_Innovative Therapeutic Strategies in Axial Spondyloarthritis
- Room 1 (3F)
- English (AI Translation)
- Chairs
- Tae-Hwan Kim (Hanyang Univ., Korea)
- Tae-Jong Kim (Chonnam Nat'l Univ., )
- 10:30-11:00
- Tailored therapeutic approaches for biologics and JAK inhibitors in axial spondyloarthritis
- Lianne S. Gensler (Univ. of California, San Francisco, USA)
- 11:00-11:30
- Exploring the intestinal microbiome in axial spondyloarthritis
- Francesco Ciccia (Univ. della Campania L. Vanvitelli, Italy)
- 11:30-12:00
- Optimizing biologic tapering strategies in spondyloarthritis
- Hong Ki Min (Konkuk Univ., Korea)
- May 16(Fri)
- 12:00-13:00
- Luncheon Symposium 4 [Samsung Bioepis]
- Bone Disease
- Room 1 (3F)
- Korean (AI Translation)
- Chair
- Jung Soo Song (Chung-Ang Univ., Korea)
- 12:00-13:00
- The changing landscape of bone disease management & clinical insight of Denosumab biosimilar
- Jinwuk Hur (Eulji Univ., Korea)
- May 16(Fri)
- 13:00-14:30
- International Symposium 3_Geriatrics in Rheumatology: How to Optimize the Treatment for Aging Patients
- Room 1 (3F)
- English (AI Translation)
- Chairs
- Sang-Cheol Bae (Hanyang Univ., Korea)
- Hyun-Sook Kim (Soonchunhyang Univ., Korea)
- 13:00-13:30
- The immune system's twilight: Immunosenescence and inflammaging as interconnected phenomena
- Won-Woo Lee (Seoul Nat'l Univ., Korea)
- 13:30-14:00
- Essential considerations for treating older rheumatology patients
- Una Makris (UT Southwestern Medical Center, USA)
- 14:00-14:30
- Polymyalgia rheumatica: Not an isolated disease but rather a disease spectrum
- Milena Bond (Hosp. of Brunico, Italy)
- May 16(Fri)
- 15:30-17:00
- International Symposium 4_Optimizing Treatment Strategies to Mitigate Cardiovascular Risk in Rheumatoid Arthritis Patients
- Room 1 (3F)
- English (AI Translation)
- Chairs
- Jung-Yoon Choe (Daegu Catholic Univ., Korea)
- Yoon-Kyoung Sung (Hanyang Univ., Korea)
- 15:30-16:00
- Impact of disease-modifying anti-rheumatic drugs on vascular inflammation in rheumatoid arthritis patients
- Joan M Bathon (Columbia Univ., USA)
- 16:00-16:30
- Treatment approaches for elderly rheumatoid arthritis patients in Japan: A focus on cardiovascular health
- Toshihiro Nanki (Toho Univ., Japan)
- 16:30-17:00
- Current evidence on JAK inhibitors and cardiovascular risk in Korean rheumatoid arthritis patients
- Soo-Kyung Cho (Hanyang Univ., Korea)
- May 16(Fri)
- 08:00-09:00
- Breakfast Symposium 3 [Celltrion]
- Efficacy of Infliximab SC in Treatment of axSpA
- Room 2 (3F)
- Korean (AI Translation)
- Chair
- Chang-Hee Suh (Ajou Univ., Korea)
- 08:00-09:00
- Real-world evidence of IFX SC in treatment of axSpA
- Sang-Hoon Lee (Kyung Hee Univ., Korea)
- May 16(Fri)
- 10:30-12:00
- Free Paper Session 6_Rheumatoid Arthritis (I)
- Room 2 (3F)
- English (AI Translation)
- Chairs
- Jinseok Kim (Jeju Nat'l Univ., Korea)
- Sung Won Lee (Dong-A Univ., Korea)
- 10:30-10:40
- (KO-030) Clinical characteristics and management for flares in patients with rheumatoid arthritis treated with biologic and targeted synthetic disease-modifying antirheumatic drugs: Results from the KOBIO registry
- Young Eun Kim (Univ. of Ulsan, Korea)
- 10:40-10:50
- (KO-031) Outcomes of tapering biologic and targeted synthetic disease modifying antirheumatic drugs in rheumatoid arthritis: A multicenter randomized non-inferiority trial
- Sung-Eun Choi (Chonnam Nat'l Univ., Korea)
- 10:50-11:00
- (KO-032) Impact of disease duration on quality-of-life outcomes in rheumatoid arthritis receiving biologic DMARDs or JAK inhibitors
- Se Rim Choi (Hanyang Univ., Korea)
- 11:00-11:10
- (KO-033) Investigating the impact of biological and targeted synthetic disease-modifying anti-rheumatic drugs on rheumatoid arthritis: Insights from mendelian randomization
- Mihye Kwon (Konyang Univ. Hosp., Korea)
- 11:10-11:20
- (KO-034) APOA2 and dyslipidemia: Potential predictors of rheumatoid arthritis-associated interstitial lung disease
- Eunji Jeong (Kyung Hee Univ., Korea)
- 11:20-11:30
- (KO-035) Risk stratification in rheumatoid arthritis-associated interstitial lung disease: A novel prediction model incorporating biomarkers
- Sung Hae Chang (Soonchunhyang Univ., Korea)
- 11:30-11:40
- (KO-036) Exploring potential drugs with dual anti-rheumatic and anti-fibrotic efficacy for rheumatoid arthritis-associated interstitial lung disease
- Misong Kim (Kyung Hee Univ., Korea)
- 11:40-11:50
- (KO-037) Clinical outcome of lung transplantation in patients with connective tissue disease-related interstitial lung disease: A retrospective cohort study
- Ju Yeon Kim (Chung-Ang Univ., Korea)
- May 16(Fri)
- 12:00-13:00
- Luncheon Symposium 5 [Eisai Korea Inc.]
- A Well-balanced JAKi for Patients with RA
- Room 2 (3F)
- English (AI Translation)
- Chair
- Ji Hyeon Ju (The Catholic Univ. of Korea, Korea)
- 12:00-13:00
- The role of Jyseleca in rheumatoid arthritis: Insights from the Japanese experience
- Tomohiro Koga (Nagasaki Univ., Japan)
- May 16(Fri)
- 13:00-14:30
- Free Paper Session 8_Rheumatoid Arthritis (II)
- Room 2 (3F)
- English (AI Translation)
- Chairs
- Young Mo Kang (Kyungpook Nat'l Univ., Korea)
- Chan Hong Jeon (Soonchunhyang Univ., Korea)
- 13:00-13:10
- (KO-047) Saliva-based proteomic profiling to identify biomarkers for seronegative rheumatoid arthritis
- Eunji Jeong (Kyung Hee Univ., Korea)
- 13:10-13:20
- (KO-048) Mitochondrial transplantation ameliorates rheumatoid arthritis by targeting abnormal cGAS-STING1 signaling activation, autophagosome accumulation, and necroptosis
- Aram Lee (The Catholic Univ. of Korea, Korea)
- 13:20-13:30
- (KO-049) MtSTAT3 suppresses rheumatoid arthritis by regulating Th17 and synovial fibroblast inflammatory cell death with IL-17-mediated autophagy dysfunction
- Seon-Yeong Lee (The Catholic Univ. of Korea, Korea)
- 13:30-13:40
- (KO-050) Tacrolimus reduced cell viability of rheumatoid arthritis fibroblast-like synoviocytes through inhibition of autophagy flux
- Kyung Me Kim (Eulji Univ., Korea)
- 13:40-13:50
- (KO-051) Bifidobacterium longum BFD1R alleviates rheumatoid arthritis by modulating TDCA to inhibit IL-17 production and osteoclast differentiation
- JooYeon Jhun (The Catholic Univ. of Korea, Korea)
- 13:50-14:00
- (KO-052) The detrimental effects of intra-articular injections of umbilical cord blood-derived mesenchymal stem cells on pannus invasiveness
- Sungeun Kim (Seoul Nat'l Univ., Korea)
- 14:00-14:10
- (KO-053) AI-driven integration of single-cell transcriptomics and spatial immune modeling to predict treatment resistance in rheumatoid arthritis
- Prihantini Prihantini (The Integrated Mathematical, Computational, and Data Science for BioMedicine Research Foundation, Indonesia)
- 14:10-14:20
- (KO-054) Predicting side effects of methotrexate mono- or combination therapy in patients with rheumatoid arthritis using explainable machine learning: A nationwide multicenter cohort study
- Ki Won Moon (Kangwon Nat'l Univ., Korea)
- May 16(Fri)
- 15:30-16:30
- Free Paper Session 9_Rheumatoid Arthritis (III)
- Room 2 (3F)
- English (AI Translation)
- Chairs
- Hyun Ah Kim (Hallym Univ., Korea)
- Jaejoon Lee (Sungkyunkwan Univ., Korea)
- 15:30-15:40
- (KO-056) Association between rheumatoid arthritis and carotid atherosclerotic plaques in the elderly
- Ngoc Son Dang (Univ. Medical Center HCMC, Vietnam)
- 15:40-15:50
- (KO-057) Longitudinal study on the impact of inflammatory markers and lipid changes on cardiovascular events in rheumatoid arthritis patients: A 17-year follow-up
- Somin Lee (Kyunghee University, Korea)
- 15:50-16:00
- (KO-058) High dose folic acid supplement is associated with increased cardiovascular risk in rheumatoid arthritis patients on methotrexate
- Huan Meng (The Chinese Univ. of Hong Kong, China)
- 16:00-16:10
- (KO-059) Baseline mood status and biologic and targeted synthetic disease modifying antirheumatic drugs survival in rheumatoid arthritis: Insights from the Korean biologics registry
- Deok Yeong Gwon (Yonsei Univ., Korea)
- 16:20-16:30
- (KO-061) Effects of achieving SDAI remission on joint space outcomes progression in early rheumatoid arthritis: An HR-pQCT study
- Qihan Wu (The Chinese Univ. of Hong Kong, Hong Kong)
- May 16(Fri)
- 16:30-17:30
- Free Paper Session 10_Spondyloarthropathy Including Psoriatic Arthritis (II)
- Room 2 (3F)
- English (AI Translation)
- Chair
- Seong-Kyu Kim (Daegu Catholic Univ., Korea)
- 16:30-16:40
- (KO-062) Single-cell RNA sequencing reveals the critical role of innate immunity in identifying candidates for early biologics treatment in axial spondyloarthritis
- Seulkee Lee (Sungkyunkwan Univ., Korea)
- 16:40-16:50
- (KO-063) PPM1A deficiency in macrophages increases IL-1β secretion in ankylosing spondylitis
- Yeo-Jin Lee (Univ. of Ulsan, Korea)
- 16:50-17:00
- (KO-064) Allograft inflammatory factor 1, induced by activated monocytes, promotes the polarization of Th17 and Th1 cell in spondyloarthritis
- Seo Yoon Ban (Seoul Nat'l Univ., Korea)
- 17:00-17:10
- (KO-065) Osteoclast-derived Del-1 exacerbates bone formation in ankylosing spondylitis
- Seung Hoon Lee (Hanyang Univ., Korea)
- 17:10-17:20
- (KO-066) Evaluating the anti-inflammatory and therapeutic potential of tacrolimus in ankylosing spondylitis: Insights from human and murine models
- Sooin Park (Chonnam Nat'l Univ., Korea)
- May 16(Fri)
- 08:00-09:00
- Breakfast Symposium 4 [Daewoong]
- Realizing the True Value of Biosimilars
- Room 3 (5F)
- Korean (AI Translation)
- Chair
- Seung-Jae Hong (Kyung Hee Univ., Korea)
- 08:00-09:00
- New era of Biosimilar in rheumatic diseases
- Eun Hye Park (Chung-Ang Univ., Korea)
- May 16(Fri)
- 10:30-12:00
- KCR-KSID Joint Symposium
- Room 3 (5F)
- English (AI Translation)
- Chairs
- Eun Bong Lee (Seoul Nat'l Univ., Korea)
- Sang Oh Lee (Univ. of Ulsan, Korea)
- 10:30-11:00
- Immune dysregulation and long COVID
- Sung-Han Kim (Univ. of Ulsan, Korea)
- 11:00-11:30
- Post-COVID19 autoimmune diseases; Myth or reality
- Jaehun Jung (Korea Univ., Korea)
- 11:30-12:00
- How to optimize vaccine response in patients with rheumatic diseases
- Jin Kyun Park (Seoul Nat'l Univ., Korea)
- May 16(Fri)
- 12:00-13:00
- Luncheon Symposium 6 [Novartis]
- Spotlight Secukinumab in Axial Spondyloarthritis
- Room 3 (5F)
- English (AI Translation)
- Chair
- Yong-Beom Park (Yonsei Univ., Korea)
- 12:00-13:00
- Secukinumab in axial spondyloarthritis: Advancing IL-17 inhibition for better patient outcomes
- Lianne S. Gensler (Univ. of California, San Francisco, USA)
- May 16(Fri)
- 13:00-14:30
- Free Paper Session 7_Spondyloarthropathy Including Psoriatic Arthritis (I)
- Room 3 (5F)
- English (AI Translation)
- Chairs
- Chan-Bum Choi (Hanyang Univ., Korea)
- Seonghoon Park (Daegu Catholic Univ., Korea)
- 13:00-13:10
- (KO-038) Nationwide specialty-based analysis of TNF inhibitor rse and retention in axial spondyloarthritis using national health insurance data
- Bon San Koo (Inje Univ., Korea)
- 13:10-13:20
- (KO-039) Persistence of second-line targeted therapies after TNF-α inhibitor use in ankylosing spondylitis
- Yu-Seon Jung (Hanyang Univ., Korea)
- 13:20-13:30
- (KO-040) Retention rate of TNF inhibitors versus IL-17 inhibitors in ankylosing spondylitis patients with prior biologics experience
- Jiwon Yang (The Catholic Univ. of Korea, Korea)
- 13:30-13:40
- (KO-041) Long-term non-steroidal anti-inflammatory drug use and renal function changes in patients with ankylosing spondylitis: A real-world evidence with meta-analysis from two centers
- Young Eun Kim (Univ. of Ulsan, Korea)
- 13:40-13:50
- (KO-042) Alteration of gut microbiome in ankylosing spondylitis and its association with disease activity
- Hyemin Jeong (Soonchunhyang Univ., Korea)
- 13:50-14:00
- (KO-043) Vascular effects of achieving low disease activity in axial spondylarthritis - a 2-year prospective cohort study
- Huan Meng (The Chinese Univ. of Hong Kong, China)
- 14:00-14:10
- (KO-044) Association of the driving distance, driving time, and public transit time to the hospital with the persistence of tumor necrosis factor inhibitors in patients with ankylosing spondylitis
- Seung-Geun Lee (Pusan Nat'l Univ., Korea)
- 14:10-14:20
- (KO-045) Artificial intelligence in axial spondyloarthritis diagnosis: Integrating structural and inflammatory lesions from sacrum MRI
- Seulkee Lee (Sungkyunkwan Univ., Korea)
- 14:20-14:30
- (KO-046) Reliability and validity of the Korean translation of the PSAID questionnaire
- Bon San Koo (Inje Univ., Korea)
- May 16(Fri)
- 15:30-17:30
- KOR_Health Insurance Committee Session_The Process for Insurance Coverage of Medical Procedures and Medications in the Rheumatology Field
- Room 3 (5F)
- Korean (AI Translation)
- Chairs
- Hoon-Suk Cha (Sungkyunkwan Univ., Korea)
- Chong-Hyeon Yoon (The Catholic Univ. of Korea, Korea)
- 15:30-16:00
- The process for insurance coverage of medical procedures
- Seong-hun Jeong (Ministry of Health and Welfare, Division of Health Insurance Benefits, Korea)
- 16:00-16:30
- The process of insurance coverage for medications and unmet needs in rheumatology field
- Bo Young Yoon (Inje Univ., Korea)
- 16:30-17:30
- Panel Discussion
- May 16(Fri)
- 14:30-15:30
- Poster Viewing & Poster Tour 2
- Poster Zone (5F)
- ENG/KOR
- KP-001
- Multisystem inflammatory syndrome in children (MIS-C) with hyperferritinemia: A Korean study
- Soo-Young Lee (College of Medicine, The Catholic Univ. of Korea, Korea)
- KP-002
- Characterizing infusion-related reactions in patients with rheumatoid arthritis treated with biologic synthetic DMARDs: Observations from the KOBIO registry
- Ji-Won Kim (Ajou Univ., Korea)
- KP-003
- The association of renal expression of long non-coding RNA lnc-DC with clinical parameters in lupus nephritis
- So Hye Nam (Keimyung University School of Medicine, Korea)
- KP-004
- Risk of cervical intraepithelial neoplasia during Janus inhibitor treatment in patients with rheumatoid arthritis: A retrospective cohort study
- MIRA Cho (Rheumatology, Asan medical center, Korea)
- KP-005
- Severe lower limb edema complicating COVID-19 in a rheumatoid arthritis patient: A case report
- Seonghui Kang (Konyang University hospital, Korea)
- Tour_KP-006
- The role of DICAM in modulating macrophage differentiation and inflammatory responses via αvβ3 integrin signaling in rheumatoid arthritis
- Youn-Kwan Jung (Gyeongsang National University, Korea)
- Tour_KP-007
- Comparison of the incidence of interstitial lung disease in patients with seropositive rheumatoid arthritis using biologic DMARDs, JAK inhibitors, or methotrexate
- Jiyeol Yoon (Severance Hospital, Korea)
- Tour_KP-008
- Associations of 6-minute walk distance in patients with rheumatoid arthritis-associated interstitial lung disease
- Sung Hae Chang (Soonchunhyang Univ., Korea)
- Tour_KP-009
- A novel scoring system to predict a cancer development in patients with idiopathic inflammatory myopathy
- Yun Kyu Kim (Seoul Nat'l Univ. Hosp., Korea)
- KP-062
- Distinct clinical phenotype of isolated anti-U1 snRNP positive patients in a tertiary care setting: Insightsfrom a cross-sectional study
- Rahul Vijayan (Madras Medical College, India)
- KP-063
- Impact of residency outside the hospital city and driving distance on persistence of xanthine oxidase inhibitors in patients with gout: A retrospective cohort study
- Aran Kim (Pusan Nat'l Univ., Korea)
- KP-064
- Association between gouty arthritis and functional outcomes of acute cerebrovascular disease in a tertiary government hospital
- David Lance Marquez (Bicol Medical Center, Philippines)
- KP-065
- Low-dose febuxostat effectively reduces uric acid levels in gout patients with chronic kidney disease: Results from the two-year follow-up study of the Urate Lowering TheRApy (ULTRA) registry
- Yoon Jeong Oh (Uijeongbu Eulji Medical Center, Eulji University School of Medicine, Korea)
- KP-066
- Crystals on fire- gout and pseudogout flare in a patient with statin-induced rhabdomyolysis: A case report
- Eladio G Anino v (Philippine General Hospital, Philippines)
- KP-067
- Trends in the incidence and prevalence of systemic lupus erythematosus among Korean women of childbearing age: Results from nationwide population-based study, 2011-2020
- Jisoo Lee (Ewha Womans Univ., Korea)
- KP-068
- The mediating effect of sleep on the relationship between psoriasis severity and fall risk in patients with psoriatic arthritis
- Qiuling Liao (The Southwest Hospital of AM, China)
- KP-069
- Incidence and prevalence of seropositive rheumatoid arthritis among Korean women of childbearing age in the last decade
- Min Kyung Chung (Ewha Womans Univ., Korea)
- KP-070
- Digital aging, mental health, and quality of life in elderly Indonesians with rheumatoid arthritis
- Rosinta Hotmaida Pebrianti Purba (The Pranala Institute, Indonesia)
- KP-071
- Evaluation of the effectiveness of NFC chip-assisted virtual critical care monitoring in improving recovery outcomes in patients with acute Systemic Lupus Erythematosus Nephritis (SLE-N) renal failure: A multi-center non-inferiority study
- Ping Wang (Peking University People’s Hospital, China)
- KP-072
- A relapsing polychondritis presented with an intractable chronic cough accompanying acute onset visual disturbance and hearing loss
- Hyunje Kim (College of Medicine, Yeungnam University, Yeungnam University Medical Center, Korea)
- KP-073
- A case of IgG4-related disease mimicking low-grade marginal zone B-cell lymphoma
- Yunkyung Kim (Kosin University Gospel Hospital, Korea)
- KP-074
- Clinical characteristics and relapse predictors of IgG4-related disease
- Carson Chun Yin Yip (The Chinese University of Hong Kong, Hong Kong)
- KP-075
- Immunoglobulin G4-associated renal disease affecting the renal pelvis: A case study
- Yooseok Suh (St. Mary's Hospital, Korea)
- KP-076
- Sitting in pain: Global research trends on low back pain among office workers - bibliometric analysis
- Willy Febri (Universitas Muhammadiyah Palangka Raya, Indonesia)
- KP-077
- Oxidized LDL promotes chondrocyte inflammation and osteoarthritis via disruption of the TFEB-mediated autophagy-lysosome pathway
- JooYeon Jhun (The Catholic Univ. of Korea, Korea)
- KP-078
- IL-17 Induces mitochondria-associated endoplasmic reticulum membrane formation to promote inflammatory cell death and cartilage degradation in osteoarthritis
- Hyun Sik Na (The Catholic Univ. of Korea, Korea)
- KP-079
- SiRNA-based approaches to modulate sclerostin and Dickkopf-1 in bone disorders: A computational study
- Rian Ka Praja (Faculty of Medicine, Universitas Palangka Raya, Indonesia)
- KP-080
- Spanish national registry of romosozumab in patients with osteoporosis: Analysis of differential efficacy in specific subgroups: with rheumatic diseases, diabetes mellitus (DM), corticosteroid-induced osteoporosis and osteoporosis treatment-naive patients
- Marina soledad Moreno garcia (Reumatologia, Spain)
- KP-081
- Discontinuing denosumab, could it be done safety and effectively with romosozumab afterwards?
- Marina soledad Moreno garcia (Reumatologia, Spain)
- KP-082
- Analysis of effectiveness and safety of romosozumab in patients with very high risk of fracture in the Spanish population
- Marina soledad Moreno garcia (Reumatologia, Spain)
- KP-83
- Association between bone erosion volume assessed by HR-pQCT and physical function in early rheumatoid arthritis: A prospective cohort study
- Xianfeng Yan (The Chinese University of Hong Kong, Hong Kong)
- KP-084
- Factors associated with low health-related quality of life in rheumatoid arthritis with interstitial lung disease
- Bora Nam (Hanyang University Hospital for Rheumatic Diseases, Korea)
- KP-085
- CD25low Foxp3+ T cells in the small intestinal lamina rropria contribute to rheumatoid arthritis pathogenicity by promoting conversion into IL-17A-producing cells
- Sangwon Lee (Gyeongsang National University, Korea)
- KP-086
- Musculoskeletal ultrasound in the clinical observation of Tang's Bi-obstruction dispersing powder for the treatment of rheumatoid arthritis with phlegm-stasis obstruction
- Xinyi Hu (People's Hospital of Chongqing Banan District, China)
- KP-087
- Risk of cardiovascular disease in Mongolian patients with rheumatoid arthritis: A cross sectional study
- Anu Ganbaatar (Mongolian National University of Medical Sciences, Mongolia)
- KP-088
- Achieving a good response reflects regression of carotid atherosclerosis in patients with rheumatoid arthritis receiving targeted therapies
- Ji-Won Kim (Daegu Catholic Univ., Korea)
- KP-089
- The prevalence of metabolic syndrome and its influencing factors in patients with rheumatoid arthritis
- Yuyang Zhang (Peking University, China)
- KP-090
- Development and evaluation of a patient-centered decision aid to support shared decision-making for selecting targeted therapies in rheumatoid arthritis
- Yun-Jeong Choi (Hanyang University Hospital, Korea)
- KP-091
- Investigating the global research development on interstitial nephritis in Sjögren's syndrome: A bibliometric analysis
- Willy Febri (Universitas Muhammadiyah Palangka Raya, Indonesia)
- KP-092
- Atypical dermatological manifestation of Sjögren’s syndrome: Autoimmune chronic spontaneous urticaria
- Su-Jin Moon (The Catholic Univ. of Korea, Korea)
- KP-093
- Early (3-Month) and maintained (12-Month) comparative effectiveness of 5 advanced therapies in a large multinational cohort of real-world PsA patients
- Na Rae Han (Eli Lilly Korea, Korea)
- KP-094
- Effect of lactobacilli on symptom alleviation in imiquimod-induced psoriasis mouse model
- Juwon Kiim (Yonsei University, Korea)
- KP-095
- Does biological treatment induce ANA positivity in autoimmune rheumatic diseases and the clinical significance of ANA positivity
- Manikandan Gopal (Christian Medical College, Vellore, Tamilnadu, India)
- KP-096
- Baseline characteristics and efficacy in patients with radiographic AxSpA stratified by CRP level: An ixekizumab phase III trial analysis
- Na Rae Han (Eli Lilly Korea, Korea)
- KP-097
- Overutilization of biologics in psoriatic arthritis: Prescription patterns and specialty-specific disparities in Korea based on National Health Insurance data
- Bon San Koo (Inje Univ., Korea)
- KP-098
- Clinical and genetic factors associated with anti-TNF therapy initiation in ankylosing spondylitis
- Bora Nam (Hanyang University Hospital for Rheumatic Diseases, Korea)
- KP-099
- HLA-B27 status affects long-term treatment response to biologics in ankylosing spondylitis: A longitudinal analysis from the KOBIO cohort
- Min Jung Kim (Seoul Nat'l Univ., Korea)
- KP-100
- Persistent antiphospholipid antibody and its subgroups hinder patients with systemic lupus erythematosus from reaching target: A propensity-score matched real-world study
- Haoze Zhang (Peking University First Hospital, China)
- KP-101
- Concomitant diagnosis of tuberculosis pericarditis and lupus in a primigravid patient: A case report
- Angelica Jane Domalanta (Baguio General Hospital and Medical Center, Philippines)
- KP-102
- Does family history of systemic lupus erythematosus (SLE) elevate the risk of SLE among the malay patients?
- Lay-Kim Tan (Ministry of Health, Malaysia)
- KP-103
- Clinical significance of IL-2 In CD4+ Th1 cells in primary APS
- Litanshunbuer A (Peking University, China)
- KP-104
- Comparative efficacy of tacrolimus-based induction therapies in lupus nephritis: A target trial emulation study
- Yun Kyu Kim (Seoul Nat'l Univ. Hosp., Korea)
- KP-105
- Identification of systemic lupus erythematosus subgroups based on autoantibody profiles using unsupervised learning techniques: Preliminary findings from iLUPUS study
- Lay-Kim Tan (Ministry of Health, Malaysia)
- KP-106
- Systemic lupus erythematosus hospitalization in Germany 2000-2023: Trends and regional patterns
- Patrick Brzoska (Witten/Herdecke University, Faculty of Health, School of Medicine, Germany)
- KP-107
- Effect of ritiximab in lupus nephritis in Indian subcontinent - efficacy and safety data
- Manikandan Gopal (Christian Medical College, Vellore, Tamilnadu, India)
- KP-108
- Outcomes of flares and predictors of multiple flares following drug withdrawal in systemic lupus erythematosus
- Ritesh Kumar Mishra (Jawaharlal Institute of Postgraduate Medical Education and Research, India)
- KP-109
- Level of research productivity in the relationship between mesenchymal stem cells and systemic lupus erythematosus: bibliometric analysis
- Desvialin Ulfa Talitha (Universitas Islam Indonesia, Indonesia)
- KP-110
- Systemic lupus erythematosus and Evan's Syndrome in a young adult female: A case report
- Bea Eunice Aspiras (Batangas Medical Center, Philippines)
- KP-111
- Abdominal obesity, BMI, and systemic sclerosis: Insights into pre-diagnostic metabolic decline
- Su-Jin Moon (The Catholic Univ. of Korea, Korea)
- KP-112
- Sine scleroderma patient with severe pulmonary hypertension: A case report
- Ingrid Widyawanty (Faculty of medicine Universitas Indonesia, Cipto Mangunkusumo Hospital, Jakarta, Indonesia, Indonesia)
- KP-113
- Comparative efficacy of mepolizumab 100 mg, mepolizumab 300 mg and benralizumab 30 mg in eosinophilic granulomatosis with polyangiitis: A monocentric retrospective observational study
- Federica Davanzo (University of Padua, Italy)
- KP-114
- Clinical and imaging characteristic of progressed Large Vessel Vasculitis (LVV)
- Nurul Aulia Zakaria (International Islamic University Malaysia (IIUM), Malaysia)
- May 17(Sat)
- 08:00-09:00
- Breakfast Symposium 5 [Novartis]
- Revolutionizing Autoimmune Therapy
- Room 1 (3F)
- English (AI Translation)
- Chair
- Shin-Seok Lee (Chonnam Nat'l Univ., Korea)
- 08:00-09:00
- B cells at the core: Unlocking new insights in autoimmune disease
- Peter Gergely (Novartis Biomedical Research, Switzerland)
- May 17(Sat)
- 09:00-10:00
- Keynote Lecture 2
- Room 1 (3F)
- English (AI Translation)
- Chair
- Jung Soo Song (Chung-Ang Univ., Korea)
- 09:00-10:00
- Cell therapy in rheumatic diseases
- Ji Hyeon Ju (The Catholic Univ. of Korea, Korea)
- May 17(Sat)
- 10:30-12:00
- Free Paper Session 11_Epidemiology & Public Health
- Room 1 (3F)
- English (AI Translation)
- Chairs
- Sang-Heon Lee (Konkuk Univ., Korea)
- Jin Kyun Park (Seoul Nat'l Univ., Korea)
- 10:30-10:40
- (KO-067) Sex differences in treatment response to targeted therapy in rheumatoid arthritis: A post hoc analysis of a prospective cohort study
- Se Rim Choi (Hanyang Univ., Korea)
- 10:40-10:50
- (KO-068) A comparative study on the prevalence and mortality of rheumatoid arthritis across sociodemographic indexes in 2021
- Salma Humairah (Educational Univ. of Indonesia, Indonesia)
- 10:50-11:00
- (KO-069) Cervical cancer screening rates among Korean women of childbearing age with systemic lupus erythematosus
- Jinsu Park (Nat'l Health Insurance Service Ilsan Hosp., Korea)
- 11:00-11:10
- (KO-070) Cancer risk in patients with systemic lupus erythematosus: A population-based cohort study in Korea 2004–2021
- Su Jin Choi (Univ. of Ulsan, Korea)
- 11:10-11:20
- (KO-071) Trends in prevalence and drug utilization of ankylosing spondylitis in Korea (2010–2023): Insights from a nationwide study
- Yu-Seon Jung (Hanyang Univ., Korea)
- 11:20-11:30
- (KO-072) Evaluating antinuclear antibody positivity in dermatology patients to detect underlying rheumatic diseases
- Yunjung Choi (Jeonbuk Nat'l Univ., Korea)
- 11:30-11:40
- (KO-073) Study on the mechanism of pain improvement in rheumatic and autoimmune disease patients based on human factors engineering: A multi-center cohort study
- Ji Luo (People’s Hosp. of Chongqing Banan District, China)
- 11:40-11:50
- (KO-074) Musculoskeletal disorders in women of childbearing age: Global trends, socio-demographic disparities, and future projections
- Liang Luo (Hunan Univ., China)
- May 17(Sat)
- 12:00-13:00
- Luncheon Symposium 7 [Celltrion]
- Tocilizumab Biosimilar for Rheumatoid Arthritis
- Room 1 (3F)
- English (AI Translation)
- Chair
- Seung Cheol Shim (Chungnam Nat'l Univ., Korea)
- 12:00-13:00
- CT-P47(Avtozma) clinical trial review based on efficacy and safety
- Josef S. Smolen (Medical Univ. of Vienna, Austria)
- May 17(Sat)
- 13:00-14:30
- Free Paper Session 14_Osteoarthritis, Low Back Pain, and Miscellaneous
- Room 1 (3F)
- English (AI Translation)
- Chairs
- Gunwoo Kim (Daegu Fatima Hosp., Korea)
- Hyun Sik Gong (Seoul Nat'l Univ., Korea)
- 13:00-13:10
- (KO-091) Genetic variation of the vitamin D binding protein in carpal tunnel syndrome patients affects their response to vitamin D supplementation
- Ji Sup Hwang (Seoul Nat'l Univ., Korea)
- 13:10-13:20
- (KO-092) A ROS-responsive hydrogel with PdH nanoparticles for hydrogen therapy, photothermal lubrication, and senescence suppression in osteoarthritis treatment
- Tianqi Wang (Nat'l Univ. of Singapore, Singapore)
- 13:20-13:30
- (KO-093) Adenosine and guanosine-based oligonucleotide attenuates catabolic phenotypes in chondrocytes and slows progression of surgically induced osteoarthritis
- Yoonhee Kim (Kyungpook Nat'l Univ., Korea)
- 13:30-13:40
- (KO-094) Patient-specific design and fabrication of a trapeziometacarpal joint orthosis using a computed tomography image-based finite element model
- Ji Sup Hwang (Seoul Nat'l Univ., Korea)
- 13:40-13:50
- (KO-095) Association between tooth loss and radiographic progression of hand osteoarthritis: Findings from a 6-year longitudinal cohort study
- Sung-Eun Choi (Chonnam Nat'l Univ., Korea)
- 13:50-14:00
- (KO-096) Efficacy of tamoxifen in the treatment of idiopathic retroperitoneal fibrosis: A retrospective comparable cohort study
- Ruichan Si (Peking Univ., China)
- 14:00-14:10
- (KO-097) Temporal AI-driven multi-omics framework for predicting personalized flare dynamics in systemic autoimmune rheumatic diseases
- Rifaldy Fajar (The Integrated Mathematical, Computational, and Data Science for BioMedicine Research Foundation, Indonesia)
- May 17(Sat)
- 08:00-09:00
- Breakfast Symposium 6 [Johnson&Johnson]
- Durable AS Treatment Option, Golimumab
- Room 2 (3F)
- Korean (AI Translation)
- Chair
- Sung Hwan Park (The Catholic Univ. of Korea, Korea)
- 08:00-09:00
- How Golimumab shapes the future of AS patients with “Persistence”
- Seulkee Lee (Sungkyunkwan Univ., Korea)
- May 17(Sat)
- 10:30-12:00
- Free Paper Session 12_Basic Research
- Room 2 (3F)
- English (AI Translation)
- Chairs
- Seungwoo Han (Kyungpook Nat'l Univ., Korea)
- Mi-La Cho (The Catholic Univ. of Korea, Korea)
- 10:30-10:40
- (KO-075) MicroRNA-Seq analysis reveals distinct miRNA expression in juvenile and adult systemic sclerosis
- Sanghamitra Machhua (Postgraduate Institute of Medical Education and Research (PGIMER), India)
- 10:40-10:50
- (KO-076) GM-CSF-induced CD16+ macrophages in patients with systemic sclerosis associated interstitial lung disease promote fibroblast activation through TREM2-mediated mechanisms
- Sang Jin Lee (Kyungpook Nat'l Univ., Korea)
- 10:50-11:00
- (KO-077) Exosomes from adult-onset still's disease patients drive macrophage polarization and amplify inflammatory responses
- Mi-Hyun Ahn (Ajou Univ., Korea)
- 11:00-11:10
- (KO-078) TIGIT and SLAMF7 double-positive Tfh2 cells activate naive B cells, leading to the generation of IgG4 producing memory B cells in IgG4 related disease
- MinGang Kim (Seoul Nat'l Univ., Korea)
- 11:10-11:20
- (KO-079) Shared and distinct features of the gut microbiome in immune-mediated inflammatory diseases: Initial analysis from the INTEGRATE cohort study
- Hyun Sik Kim (Kyung Hee Univ., Korea)
- 11:20-11:30
- (KO-080) Cigarette smoke extract promotes joint destruction and ectopic bone formation in curdlan-injected SKG mice through DNA damage and NF-κB signaling pathway
- Chanhyeok Jeon (Hanyang Univ., Korea)
- 11:30-11:40
- (KO-081) Soluble CCR2-expressing mesenchymal stem cells inhibit osteoarthritis development and progression
- Hyun Sik Na (The Catholic Univ. of Korea, Korea)
- May 17(Sat)
- 12:00-13:00
- Luncheon Symposium 8 [Boehringer Ingelheim]
- Present and Future Perspectives on CTD-ILD Management
- Room 2 (3F)
- English (AI Translation)
- Chair
- Eun Young Lee (Seoul Nat'l Univ., Korea)
- 12:00-13:00
- Guidelines for SARD-ILD and the treatment role of antifibrotic agent
- Oliver Distler (Univ. Hosp. Zurich, Switzerland)
- May 17(Sat)
- 13:00-14:30
- KOR_General Practitioners' Session
- Room 2 (3F)
- Korean (AI Translation)
- Chairs
- Dae Hyun Yoo (Yoo & Na Rheumatology Clinic, Korea)
- YoungOk Jung (Jung's Rheumatism Clinic, Korea)
- 13:00-13:30
- Learn about cardiac arrhythmias associated with rheumatic diseases
- Jae-Sun Uhm (Yonsei Univ., Korea)
- 13:30-14:00
- Stepwise approach to cytopenia - differential diagnosis with SLE
- Young Hoon Park (Ewha Womans Univ., Korea)
- 14:00-14:30
- Screening for interstitial lung disease in the general practice
- Yeon-Ah Lee (Kyung Hee Univ., Korea)
- May 17(Sat)
- 08:00-09:00
- Breakfast Symposium 7 [ChongKunDang & Amgen]
- Advancing Osteoporosis Care in Rheumatology Patients
- Room 3 (5F)
- Korean (AI Translation)
- Chair
- Yoon-Kyoung Sung (Hanyang Univ., Korea)
- 08:00-09:00
- Why Prolia? Emphasizing its originality in preventing fractures
- Sung Soo Kim (Univ. of Ulsan, Korea)
- May 17(Sat)
- 10:30-12:00
- Free Paper Session 13_Crystal Arthropathies
- Room 3 (5F)
- English (AI Translation)
- Chairs
- Seung-Jae Hong (Kyung Hee Univ., Korea)
- Jiseon Oh (Univ. of Ulsan, Korea)
- 10:30-10:40
- (KO-082) Sex differences in Korean patients with gout: A prospective, multicenter, observational study
- You-Jung Ha (Seoul Nat'l Univ., Korea)
- 10:40-10:50
- (KO-083) Establishing a prediction model of gout in patients with asymptomatic hyperuricemia based on a common data model plus machine learning algorithms
- Min Jung Kim (Seoul Nat'l Univ., Korea)
- 10:50-11:00
- (KO-084) Association between serum uric acid & abdominal fat distribution quantified by computed tomography in Korean men: A single center study
- Minsu Han (Univ. of Ulsan, Korea)
- 11:00-11:10
- (KO-085) The effect of uric acid lowering therapy on vascular stiffness in patients with gout
- Wooseong Jeong (Jeju Nat'l Univ., Korea)
- 11:10-11:20
- (KO-086) Increased cardiovascular risk in young patients with gout: A nationwide cohort study
- Yeonghee Eun (Sungkyunkwan Univ., Korea)
- 11:20-11:30
- (KO-087) NK cells are numerically reduced but functionally activated by the MSU crystal in gout
- Ki-Jeong Park (Chonnam Nat'l Univ., Korea)
- 11:30-11:40
- (KO-088) Analysis of the role of ABCG2 in kidney cell activation by monosodium urate (MSU) crystals through transfection of a specific sgRNA using the CRISPR-Cas9 technique
- Ambar López Macay (Instituto Nacional de Rehabilitación, Mexico)
- 11:40-11:50
- (KO-089) Reverse translational biomarker bifidobacterium as therapeutic candidate for gout treatment
- Mohammed Solayman Hossain (Soonchunhyang Univ., Korea)
- 11:50-12:00
- (KO-090) Auranofin alleviates gout inflammation by suppressing migration of neutrophil via IL-33/ST2 dependent pathway
- Hyeyeon Yoo (The Catholic Univ. of Korea, Korea)
- May 17(Sat)
- 12:00-13:00
- Luncheon Symposium 9 [JW Pharmaceutical]
- Tocilizumab: Treatment of Rheumatic Diseases
- Room 3 (5F)
- Korean (AI Translation)
- Chair
- Seong-Ho Kim (Inje Univ., Korea)
- 12:00-13:00
- The role of Tocilizumab in RA and JIA treatment
- Jennifer Jooha Lee (The Catholic Univ. of Korea, Korea)
- May 17(Sat)
- 13:00-14:30
- KCR-KCPCI Joint Symposium_Adult and Pediatric Rheumatic Diseases
- Room 3 (5F)
- English (AI Translation)
- Chairs
- Yong-wook Park (Chonnam Nat'l Univ., Korea)
- Youngdae Kim (Inje Univ., Korea)
- 13:00-13:30
- Treatment Patterns in Juvenile Idiopathic Arthritis in Korea
- Dae-Chul Jeong (The Catholic Univ. of Korea, Korea)
- 13:30-14:00
- Role of inflammatory cytokines and cytokine-targeted therapy in systemic JIA and MAS
- Masaki Shimizu (Institute of Science Tokyo, Japan)
- 14:00-14:30
- bDMARDs and tsDMARDs for adult and pediatric rheumatic diseases
- Su-Jin Moon (The Catholic Univ. of Korea, Korea)
- May 17(Sat)
- 10:00-10:30
- Poster Viewing
- Poster Zone (5F)
- KP-001
- Multisystem inflammatory syndrome in children (MIS-C) with hyperferritinemia: A Korean study
- Soo-Young Lee (College of Medicine, The Catholic Univ. of Korea, Korea)
- KP-002
- Characterizing infusion-related reactions in patients with rheumatoid arthritis treated with biologic synthetic DMARDs: Observations from the KOBIO registry
- Ji-Won Kim (Ajou Univ., Korea)
- KP-003
- The association of renal expression of long non-coding RNA lnc-DC with clinical parameters in lupus nephritis
- So Hye Nam (Keimyung University School of Medicine, Korea)
- KP-004
- Risk of cervical intraepithelial neoplasia during Janus inhibitor treatment in patients with rheumatoid arthritis: A retrospective cohort study
- MIRA Cho (Rheumatology, Asan medical center, Korea)
- KP-005
- Severe lower limb edema complicating COVID-19 in a rheumatoid arthritis patient: A case report
- Seonghui Kang (Konyang University hospital, Korea)
- KP-006
- The role of DICAM in modulating macrophage differentiation and inflammatory responses via αvβ3 integrin signaling in rheumatoid arthritis
- Youn-Kwan Jung (Gyeongsang National University, Korea)
- KP-007
- Comparison of the incidence of interstitial lung disease in patients with seropositive rheumatoid arthritis using biologic DMARDs, JAK inhibitors, or methotrexate
- Jiyeol Yoon (Severance Hospital, Korea)
- KP-008
- Associations of 6-minute walk distance in patients with rheumatoid arthritis-associated interstitial lung disease
- Sung Hae Chang (Soonchunhyang Univ., Korea)
- KP-009
- A novel scoring system to predict a cancer development in patients with idiopathic inflammatory myopathy
- Yun Kyu Kim (Seoul Nat'l Univ. Hosp., Korea)
- KP-062
- Distinct clinical phenotype of isolated anti-U1 snRNP positive patients in a tertiary care setting: Insightsfrom a cross-sectional study
- Rahul Vijayan (Madras Medical College, India)
- KP-063
- Impact of residency outside the hospital city and driving distance on persistence of xanthine oxidase inhibitors in patients with gout: A retrospective cohort study
- Aran Kim (Pusan Nat'l Univ., Korea)
- KP-064
- Association between gouty arthritis and functional outcomes of acute cerebrovascular disease in a tertiary government hospital
- David Lance Marquez (Bicol Medical Center, Philippines)
- KP-065
- Low-dose febuxostat effectively reduces uric acid levels in gout patients with chronic kidney disease: Results from the two-year follow-up study of the Urate Lowering TheRApy (ULTRA) registry
- Yoon Jeong Oh (Uijeongbu Eulji Medical Center, Eulji University School of Medicine, Korea)
- KP-066
- Crystals on fire- gout and pseudogout flare in a patient with statin-induced rhabdomyolysis: A case report
- Eladio G Anino v (Philippine General Hospital, Philippines)
- KP-067
- Trends in the incidence and prevalence of systemic lupus erythematosus among Korean women of childbearing age: Results from nationwide population-based study, 2011-2020
- Jisoo Lee (Ewha Womans Univ., Korea)
- KP-068
- The mediating effect of sleep on the relationship between psoriasis severity and fall risk in patients with psoriatic arthritis
- Qiuling Liao (The Southwest Hospital of AM, China)
- KP-069
- Incidence and prevalence of seropositive rheumatoid arthritis among Korean women of childbearing age in the last decade
- Min Kyung Chung (Ewha Womans Univ., Korea)
- KP-070
- Digital aging, mental health, and quality of life in elderly Indonesians with rheumatoid arthritis
- Rosinta Hotmaida Pebrianti Purba (The Pranala Institute, Indonesia)
- KP-071
- Evaluation of the effectiveness of NFC chip-assisted virtual critical care monitoring in improving recovery outcomes in patients with acute Systemic Lupus Erythematosus Nephritis (SLE-N) renal failure: A multi-center non-inferiority study
- Ping Wan (The Southwest Hospital of AMU, China)
- KP-072
- A relapsing polychondritis presented with an intractable chronic cough accompanying acute onset visual disturbance and hearing loss
- Hyunje Kim (College of Medicine, Yeungnam University, Yeungnam University Medical Center, Korea)
- KP-073
- A case of IgG4-related disease mimicking low-grade marginal zone B-cell lymphoma
- Yunkyung Kim (Kosin University Gospel Hospital, Korea)
- KP-074
- Clinical characteristics and relapse predictors of IgG4-related disease
- Carson Chun Yin Yip (The Chinese University of Hong Kong, Hong Kong)
- KP-075
- Immunoglobulin G4-associated renal disease affecting the renal pelvis: A case study
- Yooseok Suh (St. Mary's Hospital, Korea)
- KP-076
- Sitting in pain: Global research trends on low back pain among office workers - bibliometric analysis
- Willy Febri (Universitas Muhammadiyah Palangka Raya, Indonesia)
- KP-077
- Oxidized LDL promotes chondrocyte inflammation and osteoarthritis via disruption of the TFEB-mediated autophagy-lysosome pathway
- JooYeon Jhun (The Catholic Univ. of Korea, Korea)
- KP-078
- IL-17 Induces mitochondria-associated endoplasmic reticulum membrane formation to promote inflammatory cell death and cartilage degradation in osteoarthritis
- Hyun Sik Na (The Catholic Univ. of Korea, Korea)
- KP-079
- SiRNA-based approaches to modulate sclerostin and Dickkopf-1 in bone disorders: A computational study
- Rian Ka Praja (Faculty of Medicine, Universitas Palangka Raya, Indonesia)
- KP-080
- Spanish national registry of romosozumab in patients with osteoporosis: Analysis of differential efficacy in specific subgroups: with rheumatic diseases, diabetes mellitus (DM), corticosteroid-induced osteoporosis and osteoporosis treatment-naive patients
- Marina soledad Moreno garcia (Reumatologia, Spain)
- KP-081
- Discontinuing denosumab, could it be done safety and effectively with romosozumab afterwards?
- Marina soledad Moreno garcia (Reumatologia, Spain)
- KP-082
- Analysis of effectiveness and safety of romosozumab in patients with very high risk of fracture in the Spanish population
- Marina soledad Moreno garcia (Reumatologia, Spain)
- KP-083
- Association between bone erosion volume assessed by HR-pQCT and physical function in early rheumatoid arthritis: A prospective cohort study
- Xianfeng Yan (The Chinese University of Hong Kong, Hong Kong)
- KP-084
- Factors associated with low health-related quality of life in rheumatoid arthritis with interstitial lung disease
- Bora Nam (Hanyang University Hospital for Rheumatic Diseases, Korea)
- KP-085
- CD25low Foxp3+ T cells in the small intestinal lamina rropria contribute to rheumatoid arthritis pathogenicity by promoting conversion into IL-17A-producing cells
- Sangwon Lee (Gyeongsang National University, Korea)
- KP-086
- Musculoskeletal ultrasound in the clinical observation of Tang's Bi-obstruction dispersing powder for the treatment of rheumatoid arthritis with phlegm-stasis obstruction
- Xinyi Hu (People's Hospital of Chongqing Banan District, China)
- KP-087
- Risk of cardiovascular disease in Mongolian patients with rheumatoid arthritis: A cross sectional study
- Anu Ganbaatar (Mongolian National University of Medical Sciences, Mongolia)
- KP-088
- Achieving a good response reflects regression of carotid atherosclerosis in patients with rheumatoid arthritis receiving targeted therapies
- Ji-Won Kim (Daegu Catholic Univ., Korea)
- KP-089
- The prevalence of metabolic syndrome and its influencing factors in patients with rheumatoid arthritis
- Yuyang Zhang (Peking University, China)
- KP-090
- Development and evaluation of a patient-centered decision aid to support shared decision-making for selecting targeted therapies in rheumatoid arthritis
- Yun-Jeong Choi (Hanyang University Hospital, Korea)
- KP-091
- Investigating the global research development on interstitial nephritis in Sjögren's syndrome: A bibliometric analysis
- Willy Febri (Universitas Muhammadiyah Palangka Raya, Indonesia)
- KP-092
- Atypical dermatological manifestation of Sjögren’s syndrome: Autoimmune chronic spontaneous urticaria
- Su-Jin Moon (The Catholic Univ. of Korea, Korea)
- KP-093
- Early (3-Month) and maintained (12-Month) comparative effectiveness of 5 advanced therapies in a large multinational cohort of real-world PsA patients
- Na Rae Han (Eli Lilly Korea, Korea)
- KP-094
- Effect of lactobacilli on symptom alleviation in imiquimod-induced psoriasis mouse model
- Juwon Kiim (Yonsei University, Korea)
- KP-095
- Does biological treatment induce ANA positivity in autoimmune rheumatic diseases and the clinical significance of ANA positivity
- Manikandan Gopal (Christian Medical College, Vellore, Tamilnadu, India)
- KP-096
- Baseline characteristics and efficacy in patients with radiographic AxSpA stratified by CRP level: An ixekizumab phase III trial analysis
- Na Rae Han (Eli Lilly Korea, Korea)
- KP-097
- Overutilization of biologics in psoriatic arthritis: Prescription patterns and specialty-specific disparities in Korea based on National Health Insurance data
- Bon San Koo (Inje Univ., Korea)
- KP-098
- Clinical and genetic factors associated with anti-TNF therapy initiation in ankylosing spondylitis
- Bora Nam (Hanyang University Hospital for Rheumatic Diseases, Korea)
- KP-099
- HLA-B27 status affects long-term treatment response to biologics in ankylosing spondylitis: A longitudinal analysis from the KOBIO cohort
- Min Jung Kim (Seoul Nat'l Univ., Korea)
- KP-100
- Persistent antiphospholipid antibody and its subgroups hinder patients with systemic lupus erythematosus from reaching target: A propensity-score matched real-world study
- Haoze Zhang (Peking University First Hospital, China)
- KP-101
- Concomitant diagnosis of tuberculosis pericarditis and lupus in a primigravid patient: A case report
- Angelica Jane Domalanta (Baguio General Hospital and Medical Center, Philippines)
- KP-102
- Does family history of systemic lupus erythematosus (SLE) elevate the risk of SLE among the malay patients?
- Lay-Kim Tan (Ministry of Health, Malaysia)
- KP-103
- Clinical significance of IL-2 In CD4+ Th1 cells in primary APS
- Litanshunbuer A (Peking University, China)
- KP-104
- Comparative efficacy of tacrolimus-based induction therapies in lupus nephritis: A target trial emulation study
- Yun Kyu Kim (Seoul Nat'l Univ. Hosp., Korea)
- KP-105
- Identification of systemic lupus erythematosus subgroups based on autoantibody profiles using unsupervised learning techniques: Preliminary findings from iLUPUS study
- Lay-Kim Tan (Ministry of Health, Malaysia)
- KP-106
- Systemic lupus erythematosus hospitalization in Germany 2000-2023: Trends and regional patterns
- Patrick Brzoska (Witten/Herdecke University, Faculty of Health, School of Medicine, Germany)
- KP-107
- Effect of ritiximab in lupus nephritis in Indian subcontinent - efficacy and safety data
- Manikandan Gopal (Christian Medical College, Vellore, Tamilnadu, India)
- KP-108
- Outcomes of flares and predictors of multiple flares following drug withdrawal in systemic lupus erythematosus
- Ritesh Kumar Mishra (Jawaharlal Institute of Postgraduate Medical Education and Research, India)
- KP-109
- Level of research productivity in the relationship between mesenchymal stem cells and systemic lupus erythematosus: bibliometric analysis
- Desvialin Ulfa Talitha (Universitas Islam Indonesia, Indonesia)
- KP-110
- Systemic lupus erythematosus and Evan's Syndrome in a young adult female: A case report
- Bea Eunice Aspiras (Batangas Medical Center, Philippines)
- KP-111
- Abdominal obesity, BMI, and systemic sclerosis: Insights into pre-diagnostic metabolic decline
- Su-Jin Moon (The Catholic Univ. of Korea, Korea)
- KP-112
- Sine scleroderma patient with severe pulmonary hypertension: A case report
- Ingrid Widyawanty (Faculty of medicine Universitas Indonesia, Cipto Mangunkusumo Hospital, Jakarta, Indonesia, Indonesia)
- KP-113
- Comparative efficacy of mepolizumab 100 mg, mepolizumab 300 mg and benralizumab 30 mg in eosinophilic granulomatosis with polyangiitis: A monocentric retrospective observational study
- Federica Davanzo (University of Padua, Italy)
- KP-114
- Clinical and imaging characteristic of progressed Large Vessel Vasculitis (LVV)
- Nurul Aulia Zakaria (International Islamic University Malaysia (IIUM), Malaysia)
